79 related articles for article (PubMed ID: 21073045)
21. Association between PON 1 polymorphisms, PON activity and diabetes complications.
Hofer SE; Bennetts B; Chan AK; Holloway B; Karschimkus C; Jenkins AJ; Silink M; Donaghue KC
J Diabetes Complications; 2006; 20(5):322-8. PubMed ID: 16949520
[TBL] [Abstract][Full Text] [Related]
22. Paraoxonase-1 (PON-1) genotype and activity and in vivo oxidized plasma low-density lipoprotein in Type II diabetes.
Sampson MJ; Braschi S; Willis G; Astley SB
Clin Sci (Lond); 2005 Aug; 109(2):189-97. PubMed ID: 15853770
[TBL] [Abstract][Full Text] [Related]
23. Activity of paraoxonase 1 (PON1) and its relationship to markers of lipoprotein oxidation in healthy Slovaks.
Sumegová K; Blazícek P; Waczulíková I; Zitnanová I; Duracková Z
Acta Biochim Pol; 2006; 53(4):783-7. PubMed ID: 17106515
[TBL] [Abstract][Full Text] [Related]
24. Modulation by blood glucose levels of activity and concentration of paraoxonase in young patients with type 1 diabetes mellitus.
Kordonouri O; James RW; Bennetts B; Chan A; Kao YL; Danne T; Silink M; Donaghue K
Metabolism; 2001 Jun; 50(6):657-60. PubMed ID: 11398141
[TBL] [Abstract][Full Text] [Related]
25. Effect of insulin resistance on serum paraoxonase activity in a nondiabetic population.
Yamada A; Shoji T; Tahara H; Emoto M; Nishizawa Y
Metabolism; 2001 Jul; 50(7):805-11. PubMed ID: 11436186
[TBL] [Abstract][Full Text] [Related]
26. Parameters of antioxidative defense in type 2 diabetic patients with cardiovascular complications.
Colak E; Majkić-Singh N; Stanković S; Srecković-Dimitrijević V; Djordjević PB; Lalić K; Lalić N
Ann Med; 2005; 37(8):613-20. PubMed ID: 16338763
[TBL] [Abstract][Full Text] [Related]
27. Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes.
Garin MC; James RW; Dussoix P; Blanché H; Passa P; Froguel P; Ruiz J
J Clin Invest; 1997 Jan; 99(1):62-6. PubMed ID: 9011577
[TBL] [Abstract][Full Text] [Related]
28. Gemfibrozil increases paraoxonase activity in type 2 diabetic patients. A new hypothesis of the beneficial action of fibrates?
Balogh Z; Seres I; Harangi M; Kovács P; Kakuk G; Paragh G
Diabetes Metab; 2001 Nov; 27(5 Pt 1):604-10. PubMed ID: 11694861
[TBL] [Abstract][Full Text] [Related]
29. High-density lipoprotein composition and paraoxonase activity in Type I diabetes.
Valabhji J; McColl AJ; Schachter M; Dhanjil S; Richmond W; Elkeles RS
Clin Sci (Lond); 2001 Dec; 101(6):659-70. PubMed ID: 11724654
[TBL] [Abstract][Full Text] [Related]
30. Serum paraoxonase activity and paraoxonase gene polymorphism in type 2 diabetic patients with or without vascular complications.
Letellier C; Durou MR; Jouanolle AM; Le Gall JY; Poirier JY; Ruelland A
Diabetes Metab; 2002 Sep; 28(4 Pt 1):297-304. PubMed ID: 12442067
[TBL] [Abstract][Full Text] [Related]
31. Relationship of serum paraoxonase 1 activity and paraoxonase 1 genotype to risk of systemic lupus erythematosus.
Tripi LM; Manzi S; Chen Q; Kenney M; Shaw P; Kao A; Bontempo F; Kammerer C; Kamboh MI
Arthritis Rheum; 2006 Jun; 54(6):1928-39. PubMed ID: 16729301
[TBL] [Abstract][Full Text] [Related]
32. Risk factors for nephropathy and cardiovascular disease in diabetic Northern Minnesota American Indians.
Hirata-Dulas CA; Rith-Najarian SJ; McIntyre MC; Ross C; Dahl DC; Keane WF; Kasiske BL
Clin Nephrol; 1996 Aug; 46(2):92-8. PubMed ID: 8869785
[TBL] [Abstract][Full Text] [Related]
33. Serum paraoxonase activities in hemodialyzed uremic patients: cohort study.
Juretić D; Tadijanović M; Rekić B; Simeon-Rudolf V; Reiner E; Baricić M
Croat Med J; 2001 Apr; 42(2):146-50. PubMed ID: 11259735
[TBL] [Abstract][Full Text] [Related]
34. Relationship between human paraoxonase-1 activity and PON1 polymorphisms in Mexican workers exposed to organophosphate pesticides.
López-Flores I; Lacasaña M; Blanco-Muñoz J; Aguilar-Garduño C; Sanchez-Villegas P; Pérez-Méndez OA; Gamboa-Avila R
Toxicol Lett; 2009 Jul; 188(2):84-90. PubMed ID: 19446239
[TBL] [Abstract][Full Text] [Related]
35. The paraoxonase-2-310 polymorphism is associated with the presence of microvascular complications in diabetes mellitus.
Mackness B; McElduff P; Mackness MI
J Intern Med; 2005 Oct; 258(4):363-8. PubMed ID: 16164576
[TBL] [Abstract][Full Text] [Related]
36. Non-insulin-dependent diabetes and 11-year mortality in Asian Indian and Melanesian Fijians.
Collins VR; Dowse GK; Ram P; Cabealawa S; Zimmet PZ
Diabet Med; 1996 Feb; 13(2):125-32. PubMed ID: 8641116
[TBL] [Abstract][Full Text] [Related]
37. Association of serum paraoxonase activity with insulin sensitivity and oxidative stress in hyperthyroid and TSH-suppressed nodular goitre patients.
Yavuz DG; Yüksel M; Deyneli O; Ozen Y; Aydin H; Akalin S
Clin Endocrinol (Oxf); 2004 Oct; 61(4):515-21. PubMed ID: 15473886
[TBL] [Abstract][Full Text] [Related]
38. Smoking is associated with reduced serum levels of the antioxidant enzyme, paraoxonase, in Type 2 diabetic patients.
Boemi M; Sirolla C; Testa R; Cenerelli S; Fumelli P; James RW
Diabet Med; 2004 May; 21(5):423-7. PubMed ID: 15089785
[TBL] [Abstract][Full Text] [Related]
39. Tissue plasminogen activator (tPA) activity is a novel and early marker of asymptomatic LEAD in type 2 diabetes.
Sahli D; Eriksson JW; Boman K; Svensson MK
Thromb Res; 2009 Mar; 123(5):701-6. PubMed ID: 18945481
[TBL] [Abstract][Full Text] [Related]
40. Oxidative stress and high-density lipoprotein function in Type I diabetes and end-stage renal disease.
Kalogerakis G; Baker AM; Christov S; Rowley KG; Dwyer K; Winterbourn C; Best JD; Jenkins AJ
Clin Sci (Lond); 2005 Jun; 108(6):497-506. PubMed ID: 15634192
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
